Peptide and Oligonucleotide CDMO Market Size, 2032 Report

The peptide and oligonucleotide CDMO market size surpassed USD 2.3 billion in 2023 and estimated to exhibit 12.1% CAGR between 2024 and 2032, driven by the increasing demand for personalized medicine and targeted therapies, requiring customized peptides and oligonucleotides.

2023年，多肽和寡核苷酸合同开发与生产组织（CDMO）市场规模已突破23亿美元，预计在2024年至2032年期间将保持12.1%的复合年增长率，这一增长动力源于对个性化医疗和靶向治疗需求的不断上升，此类治疗需依赖于定制的多肽和寡核苷酸。